Free Trial
→ I'm giving you a space stock today. Free. (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.17
-0.7%		$0.26
$0.16
▼
$1.86
$20.91M1.4221.08 million shs2.48 million shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.78
-2.5%		$0.85
$0.75
▼
$1.94
$84.85M1.451.24 million shs949,776 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$32.19
-3.0%		$35.40
$32.00
▼
$46.57
$96.07M0.765,484 shs659 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$7.74
+18.5%		$6.58
$2.21
▼
$9.33
$97.20M1.38137,187 shs1.12 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
-0.74%-28.00%-24.60%-32.97%-90.40%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-2.50%-17.02%-2.63%-16.18%-64.54%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-2.98%-4.82%-8.71%-15.53%-23.74%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
+18.53%+14.33%+35.79%+14.67%+132.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.17
-0.7%		$0.26
$0.16
▼
$1.86
$20.91M1.4221.08 million shs2.48 million shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.78
-2.5%		$0.85
$0.75
▼
$1.94
$84.85M1.451.24 million shs949,776 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$32.19
-3.0%		$35.40
$32.00
▼
$46.57
$96.07M0.765,484 shs659 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$7.74
+18.5%		$6.58
$2.21
▼
$9.33
$97.20M1.38137,187 shs1.12 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
-0.74%-28.00%-24.60%-32.97%-90.40%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-2.50%-17.02%-2.63%-16.18%-64.54%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-2.98%-4.82%-8.71%-15.53%-23.74%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
+18.53%+14.33%+35.79%+14.67%+132.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accuray Incorporated stock logo
ARAY
Accuray
1.67
Reduce$2.001,050.75% Upside
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.40
Hold$2.03160.65% Upside
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
2.00
HoldN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
2.50
Moderate Buy$13.0067.96% Upside

Current Analyst Ratings Breakdown

Latest ARAY, KEQU, HYPR, and NRXS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/2/2026
NeurAxis, Inc. stock logo
NRXS
NeurAxis
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold
9/25/2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingHold (C)
9/22/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$2.00
9/14/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$2.00
9/1/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
8/20/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$2.00
8/10/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$2.00 ➝ $1.60
8/4/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (D-)
7/17/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (D-)
(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accuray Incorporated stock logo
ARAY
Accuray
$401.95M0.05N/AN/A$0.35 per share0.50
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$16.54M5.00N/AN/A$0.42 per share1.86
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$282M0.33$5.78 per share5.57$26.80 per share1.20
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$5.32M18.28N/AN/A($0.27) per share-28.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accuray Incorporated stock logo
ARAY
Accuray
-$49.19M-$0.40N/AN/AN/A-12.24%-97.85%-10.82%11/4/2026 (Estimated)
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$35.57M-$0.38N/AN/AN/A-210.75%-97.88%-61.81%11/9/2026 (Confirmed)
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$9.62M$2.7611.40N/AN/A2.97%11.61%4.82%12/16/2026 (Estimated)
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-$14.63M-$0.78N/AN/AN/A-492.76%N/A-641.25%11/9/2026 (Estimated)

Latest ARAY, KEQU, HYPR, and NRXS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.08N/AN/AN/A$5.79 millionN/A
11/9/2026N/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-$0.21N/AN/AN/A$2.10 millionN/A
11/4/2026Q1 2027
Accuray Incorporated stock logo
ARAY
Accuray
-$0.07N/AN/AN/A$95.80 millionN/A
9/9/2026Q1 2027
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/A$0.58N/A$0.58N/A$66.32 million
8/19/2026Q4 2026
Accuray Incorporated stock logo
ARAY
Accuray
-$0.03-$0.02+$0.01-$0.02$105.30 million$100.92 million
8/6/2026Q2 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$4.14 million$3.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/AN/AN/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Accuray Incorporated stock logo
ARAY
Accuray
3.51
1.50
0.74
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.36
6.15
5.45
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.51
2.20
1.57
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/A
0.24
0.23

Institutional Ownership

CompanyInstitutional Ownership
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
32.69%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
11.77%

Insider Ownership

CompanyInsider Ownership
Accuray Incorporated stock logo
ARAY
Accuray
2.40%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
26.33%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
14.10%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
21.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accuray Incorporated stock logo
ARAY
Accuray
809119.44 million116.57 millionOptionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
102106.05 million78.13 millionOptionable
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
1,2312.90 million2.49 millionNot Optionable
NeurAxis, Inc. stock logo
NRXS
NeurAxis
2412.56 million6.09 millionNot Optionable

Recent News About These Companies

Aetna deems IB-Stim by NeurAxis medically necessary
October 15 at 1:32 PM  |  tipranks.comhttps://www.tipranks.com/news/the-fly/aetna-deems-ib-stim-by-neuraxis-medically-necessary-thefly-news
NeurAxis Announces Major National Insurer Coverage Expansion for IB-Stim Penetrating 26 Million Medical Plan Members
October 15 at 9:31 AM  |  quiverquant.comQ
NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
October 15 at 9:18 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/15/3381751/0/en/neuraxis-announces-medical-policy-coverage-milestone-expanding-access-to-26-million-additional-covered-lives.html
NeurAxis Declares Q3 Stock Dividend on Preferred Shares
October 14 at 5:31 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/neuraxis-declares-q3-stock-dividend-on-preferred-shares?utm_source=marketbeat.com&utm_medium=referral
NovoCure (NASDAQ:NVCR) versus NeurAxis (NASDAQ:NRXS) Head-To-Head Analysis
October 12, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31110894
Contrasting NeurAxis (NASDAQ:NRXS) & Solventum (NYSE:SOLV)
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31086310
What is Craig Hallum's Forecast for NeurAxis Q3 Earnings?
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31085389
NeurAxis, Inc. Announces Appointment of Craig Blanchard as Chief Commercial Officer
September 29, 2026  |  marketscreener.comM
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
September 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/29/3370660/0/en/neuraxis-positions-for-next-phase-of-commercial-growth-with-appointment-of-craig-blanchard-as-chief-commercial-officer.html
NeurAxis Shares Surge 25% On New Insurer Coverage
September 16, 2026  |  rttnews.comhttps://www.rttnews.com/3691580/neuraxis-shares-surge-25-on-new-insurer-coverage.aspx
NeurAxis Expands PENFS Coverage By 18 Million Lives As IB-Stim Adoption Grows; Stock Up
September 16, 2026  |  rttnews.comhttps://www.rttnews.com/3691572/neuraxis-expands-penfs-coverage-by-18-million-lives-as-ib-stim-adoption-grows-stock-up.aspx
Biotech Stocks See Fresh Catalysts: Tempest, DataMEDS, NeurAxis & MAIA
September 16, 2026  |  rttnews.comhttps://www.rttnews.com/3691622/biotech-stocks-see-fresh-catalysts-tempest-datameds-neuraxis-maia.aspx
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
September 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3363241/0/en/neuraxis-announces-medical-coverage-policy-milestone-expanding-access-to-over-18-million-additional-covered-lives.html
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
September 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3363046/0/en/neuraxis-to-participate-in-the-lytham-partners-fall-2026-investor-conference.html
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
September 15, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2990000/neuraxis-gains-nearly-137-in-a-year-what-s-driving-the-stock?cid=cs-stocknewsapi-ft-microcap_article|investment_ideas-2990000
NeurAxis, Inc. (NRXS) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946498-neuraxis-inc-nrxs-presents-at-iaccess-alpha-virtual-best-ideas-fall-investment-conference
Is Kodak having a "Kodak moment?" 2 watchlist stocks.
September 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2988740/is-kodak-having-a-kodak-moment-2-watchlist-stocks?cid=cs-stocknewsapi-ft-microcap_article-2988740
NeurAxis Enhances Executive and Director Equity Compensation
August 19, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/neuraxis-enhances-executive-and-director-equity-compensation?utm_source=marketbeat.com&utm_medium=referral
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
August 14, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2975155/nrxs-stock-dips-post-q2-earnings-despite-revenue-surge-gross-margin-up?cid=cs-stocknewsapi-ft-microcap_article|earnings-2975155
NeurAxis (NRXS) Q2 2026 Earnings Call Transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuraxis-nrxs-q2-2026-earnings-012824060.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
Shopping bags sit on a polished marble floor inside an upscale retail store or shopping mall.
3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
By Nathan Reiff | September 16, 2026
An oil tanker anchored near a port terminal with storage tanks and hills visible in the background.
The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
By Thomas Hughes | September 17, 2026
Illuminated Nike swoosh logo on a wall above a display pedestal with sneakers in a retail store.
Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
By Thomas Hughes | October 4, 2026
Hands trade cash and stock documents across boardroom table, symbolizing insider buying and selling activity.
3 Stocks Under the Microscope After Large Insider Sales
By Leo Miller | September 28, 2026
Accuray stock logo

Accuray NASDAQ:ARAY

$0.17 0.00 (-0.74%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$0.18 +0.01 (+3.57%)
As of 10/15/2026 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$0.78 -0.02 (-2.50%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$0.80 +0.02 (+2.42%)
As of 10/15/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Kewaunee Scientific stock logo

Kewaunee Scientific NASDAQ:KEQU

$32.19 -0.99 (-2.98%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$32.13 -0.06 (-0.19%)
As of 10/15/2026 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

NeurAxis stock logo

NeurAxis NASDAQ:NRXS

$7.74 +1.21 (+18.53%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$7.78 +0.04 (+0.52%)
As of 10/15/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas